NIT
NumerixS Investment Technologies Portfolio holdings
AUM
$358M
1-Year Return
3.62%
This Quarter Return
-25.42%
1 Year Return
+3.62%
3 Year Return
+24.42%
5 Year Return
+34.25%
10 Year Return
–
AUM
$196M
AUM Growth
-$312M
(-61%)
Cap. Flow
-$232M
Cap. Flow
% of AUM
-118.44%
Top 10 Holdings %
Top 10 Hldgs %
20.65%
Holding
1,410
New
393
Increased
194
Reduced
371
Closed
445
Top Buys
| 1 |
Microsoft
MSFT
|
+$4.2M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$2.54M |
| 3 |
Sysco
SYY
|
+$2.24M |
| 4 |
Salesforce
CRM
|
+$2.17M |
| 5 |
Bank of America
BAC
|
+$2.03M |
Top Sells
| 1 |
Netflix
NFLX
|
+$16.2M |
| 2 |
Uber
UBER
|
+$14M |
| 3 |
Amazon
AMZN
|
+$11.2M |
| 4 |
Apple
AAPL
|
+$9.88M |
| 5 |
Starbucks
SBUX
|
+$5.05M |
Sector Composition
| 1 | Consumer Discretionary | 24.33% |
| 2 | Technology | 15.39% |
| 3 | Financials | 12.49% |
| 4 | Healthcare | 11.87% |
| 5 | Industrials | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
601
CRISPR Therapeutics
CRSP
$4.78B
| $51K | 0.03% |
1,206
-26,189
| -96% | -$1.11M |
|
602
Fate Therapeutics
FATE
$114M
| $51K | 0.03% |
+2,300
| New | +$51K |
|
603
Palomar
PLMR
$3.24B
| $51K | 0.03% |
+885
| New | +$51K |
|
|
ONC
604
BeOne Medicines Ltd. American Depositary Shares
ONC
$35.9B
| $51K | 0.03% |
416
-1,284
| -76% | -$157K |
|
|
CORE
605
DELISTED
Core Mark Holding Co., Inc.
CORE
| $51K | 0.03% |
+1,800
| New | +$51K |
|
606
Apellis Pharmaceuticals
APLS
$3.32B
| $50K | 0.03% |
+1,854
| New | +$50K |
|
607
Ashland
ASH
$2.42B
| $50K | 0.03% |
+1,000
| New | +$50K |
|
608
Extra Space Storage
EXR
$30.8B
| $50K | 0.03% |
523
-697
| -57% | -$66.6K |
|
609
InterContinental Hotels
IHG
$18.7B
| $50K | 0.03% |
1,198
-402
| -25% | -$16.8K |
|
610
Prudential
PUK
$35.3B
| $50K | 0.03% |
2,069
-302
| -13% | -$7.3K |
|
611
SSR Mining
SSRM
$4.4B
| $50K | 0.03% |
+4,403
| New | +$50K |
|
612
Choice Hotels
CHH
$5.22B
| $49K | 0.03% |
+797
| New | +$49K |
|
613
Criteo
CRTO
$1.23B
| $49K | 0.03% |
6,211
+1,100
| +22% | +$8.68K |
|
614
Diodes
DIOD
$2.45B
| $49K | 0.03% |
+1,200
| New | +$49K |
|
615
Everest Group
EG
$14.1B
| $49K | 0.03% |
+254
| New | +$49K |
|
616
Photronics
PLAB
$1.33B
| $49K | 0.03% |
+4,800
| New | +$49K |
|
617
Sarepta Therapeutics
SRPT
$1.85B
| $49K | 0.03% |
500
+300
| +150% | +$29.4K |
|
618
Axos Financial
AX
$5.2B
| $48K | 0.02% |
2,625
+2,425
| +1,213% | +$44.3K |
|
619
Diamondback Energy
FANG
$40B
| $48K | 0.02% |
+1,833
| New | +$48K |
|
620
Globus Medical
GMED
$7.88B
| $48K | 0.02% |
1,120
-2,580
| -70% | -$111K |
|
621
US Physical Therapy
USPH
$1.26B
| $48K | 0.02% |
700
-100
| -13% | -$6.86K |
|
|
AVTA
622
DELISTED
Avantax, Inc. Common Stock
AVTA
| $48K | 0.02% |
+4,000
| New | +$48K |
|
623
Apollo Global Management
APO
$77.7B
| $47K | 0.02% |
+1,400
| New | +$47K |
|
624
Collegium Pharmaceutical
COLL
$1.19B
| $47K | 0.02% |
+2,900
| New | +$47K |
|
625
Lazard
LAZ
$5.24B
| $47K | 0.02% |
+2,000
| New | +$47K |
|